Rhenman & Partners Asset Management AB - Q3 2022 holdings

$955 Million is the total value of Rhenman & Partners Asset Management AB's 90 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 14.0% .

 Value Shares↓ Weighting
LLY BuyLILLY ELI & CO$35,123,000
+20.4%
97,000
+7.8%
3.68%
+11.0%
UNH SellUNITED HEALTH GROUP INC$30,422,000
+5.8%
54,800
-2.1%
3.19%
-2.5%
BSX SellBOSTON SCIENTIFIC CORP$29,961,000
+10.9%
695,000
-4.1%
3.14%
+2.2%
VRTX BuyVERTEX PHARMACEUTICALS INC$29,952,000
+11.9%
96,000
+1.1%
3.14%
+3.1%
TMO BuyTHERMO FISHER SCIENTIFIC INC$26,983,000
+33.9%
52,500
+41.5%
2.82%
+23.4%
HUM BuyHUMANA INC$24,556,000
+22.0%
44,000
+2.3%
2.57%
+12.4%
CI SellCIGNA CORP NEW$24,230,000
-17.2%
75,000
-32.4%
2.54%
-23.7%
REGN BuyREGENERON PHARMACEUTICALS$23,960,000
+189.5%
32,000
+128.6%
2.51%
+166.9%
ABBV SellABBVIE INC$21,905,000
-24.7%
149,626
-21.2%
2.29%
-30.6%
ANTM SellELEVANCE HEALTH INC$21,871,000
-20.5%
40,000
-29.8%
2.29%
-26.7%
MRK SellMERCK & CO. INC$21,758,000
-9.9%
215,000
-18.9%
2.28%
-17.0%
ABMD BuyABIOMED INC$21,654,000
+19.8%
85,900
+17.7%
2.27%
+10.4%
ABC BuyAMERISOURCEBERGEN CORP$21,382,000
+20.9%
136,000
+8.8%
2.24%
+11.4%
CVS SellCVS HEALTH CORP$21,308,000
-20.7%
225,000
-22.4%
2.23%
-26.9%
GILD BuyGILEAD SCIENCES INC$21,184,000
+71.4%
270,000
+35.0%
2.22%
+57.9%
MDT BuyMEDTRONIC PLC$20,962,000
+55.7%
240,000
+60.0%
2.20%
+43.5%
BMRN BuyBIOMARIN PHARMACEUTICAL INC$20,531,000
+77.0%
237,000
+69.3%
2.15%
+63.1%
BDX BuyBECTON DICKINSON & CO$20,057,000
+80.8%
85,000
+88.9%
2.10%
+66.7%
MCK SellMCKESSON CORP$19,469,000
-5.3%
50,000
-20.6%
2.04%
-12.7%
JAZZ SellJAZZ PHARMACEUTICALS PLC$18,908,000
-24.3%
131,500
-17.8%
1.98%
-30.2%
JNJ  JOHNSON & JOHNSON$17,397,000
-2.0%
100,0000.0%1.82%
-9.7%
PFE SellPFIZER INC$16,293,000
-42.5%
350,000
-35.2%
1.71%
-47.0%
DHR BuyDANAHER CORPORATION$15,604,000
+14.0%
62,000
+14.8%
1.63%
+5.1%
ALNY  ALNYLAM PHARMACEUTICALS INC$15,545,000
+42.1%
75,0000.0%1.63%
+31.0%
AXNX SellAXONICS INC$15,359,000
+12.9%
210,000
-12.5%
1.61%
+4.1%
THC BuyTENET HEALTHCARE CORP$15,260,000
+11.2%
344,000
+31.8%
1.60%
+2.5%
BNTX BuyBIONTECH SEsponsored ads$13,626,000
+1.5%
99,000
+10.0%
1.43%
-6.4%
APLS BuyAPELLIS PHARMACEUTICALS INC$13,308,000
+40.1%
220,000
+4.8%
1.39%
+29.1%
MRTX BuyMIRATI THERAPEUTICS INC$13,267,000
+4.0%
197,067
+3.7%
1.39%
-4.1%
COO BuyCOOPER COS INC$12,823,000
+10.7%
46,902
+26.8%
1.34%
+2.1%
HRMY SellHARMONY BIOSCIENCES HLDGS IN$12,324,000
-2.8%
237,000
-8.8%
1.29%
-10.5%
ISRG SellINTUITIVE SURGICAL INC$12,324,000
-12.3%
50,000
-28.6%
1.29%
-19.2%
INSP BuyINSPIRE MED SYS INC$12,282,000
+34.5%
63,000
+26.0%
1.29%
+23.9%
ABT SellABBOTT LABS$11,576,000
-37.3%
117,000
-31.2%
1.21%
-42.3%
NBIX SellNEUROCRINE BIOSCIENCES INC$9,555,000
+3.2%
83,000
-12.6%
1.00%
-4.8%
HCA BuyHCA HEALTHCARE INC$9,351,000
+122.5%
43,000
+72.0%
0.98%
+105.2%
BIIB NewBIOGEN INC$9,292,00032,782
+100.0%
0.97%
PRVA SellPRIVIA HEALTH GROUP INC$9,274,000
+6.2%
277,000
-7.7%
0.97%
-2.2%
CYTK SellCYTOKINETICS INC$9,169,000
+1.5%
210,000
-8.7%
0.96%
-6.5%
RPRX BuyROYALTY PHARMA PLC$9,099,000
+44.3%
215,000
+43.3%
0.95%
+33.1%
EW BuyEDWARDS LIFESCIENCES CORP$9,054,000
+111.6%
125,000
+177.8%
0.95%
+95.1%
ISEE BuyIVERIC BIO INC$8,731,000
+263.0%
365,000
+46.0%
0.91%
+234.8%
RVNC SellREVANCE THERAPEUTICS INC$8,656,000
+39.2%
388,000
-13.8%
0.91%
+28.1%
IMCR BuyIMMUNOCORE HLDGS PLCads$8,571,000
+64.1%
150,000
+7.1%
0.90%
+51.3%
DVAX SellDYNAVAX TECHNOLOGIES CORP$8,399,000
-16.6%
733,519
-8.3%
0.88%
-23.2%
XNCR SellXENCOR INC$8,234,000
+0.3%
294,076
-2.0%
0.86%
-7.6%
HZNP SellHORIZON THERAPEUTICS PUB L$8,102,000
-68.8%
130,000
-60.0%
0.85%
-71.2%
PODD NewINSULET CORP$7,505,00029,000
+100.0%
0.79%
ESPR  ESPERION THERAPEUTICS INC NE$7,317,000
+27.8%
900,0000.0%0.77%
+17.8%
SILK SellSILK RD MED INC$6,832,000
+7.3%
155,000
-11.4%
0.72%
-1.2%
BuyR1 RCM INC$6,675,000
-2.0%
378,000
+16.3%
0.70%
-9.7%
IMGN SellIMMUNOGEN INC$6,534,000
+21.0%
1,100,000
-8.3%
0.68%
+11.4%
SWAV SellSHOCKWAVE MEDICAL INC$5,863,000
-56.8%
20,000
-71.8%
0.61%
-60.2%
VEEV SellVEEVA SYS INC$5,794,000
-23.0%
34,500
-9.2%
0.61%
-29.0%
ITCI SellINTRA-CELLULAR THERAPIES INC$5,709,000
-28.6%
125,000
-10.7%
0.60%
-34.1%
OM BuyOUTSET MED INC$5,284,000
+97.5%
340,000
+88.9%
0.55%
+81.9%
SGEN SellSEAGEN INC$5,214,000
-34.8%
41,000
-9.3%
0.55%
-39.9%
AGL BuyAGILON HEALTH INC$5,062,000
+40.5%
255,000
+54.5%
0.53%
+29.6%
IOVA SellIOVANCE BIOTHERAPEUTICS INC$4,763,000
-18.6%
510,000
-3.8%
0.50%
-25.0%
GKOS SellGLAUKOS CORP$4,766,000
+16.6%
85,000
-5.5%
0.50%
+7.5%
NVST NewENVISTA HOLDINGS CORPORATION$4,747,000143,800
+100.0%
0.50%
KRTX NewKARUNA THERAPEUTICS INC$4,387,00020,000
+100.0%
0.46%
VRAY  VIEWRAY INC$4,290,000
+61.9%
1,000,0000.0%0.45%
+49.2%
MGTX BuyMEIRAGTX HLDGS PLC$4,035,000
+6.6%
555,030
+11.0%
0.42%
-1.6%
PGNY  PROGYNY INC$4,002,000
+53.0%
90,0000.0%0.42%
+41.1%
GTHX BuyG1 THERAPEUTICS INC$3,944,000
+152.5%
370,000
+17.0%
0.41%
+133.3%
WST NewWEST PHARMACEUTICAL SVSC INC$3,912,00017,000
+100.0%
0.41%
TDOC BuyTELADOC HEALTH INC$3,853,000
+36.5%
130,000
+52.9%
0.40%
+25.5%
NTRA NewNATERA INC$3,757,00080,000
+100.0%
0.39%
ALHC NewALIGNMENT HEALTHCARE INC$3,640,000274,950
+100.0%
0.38%
SGMO BuySANGAMO THERAPEUTICS INC$3,600,000
+24.2%
820,000
+17.1%
0.38%
+14.6%
OLK BuyOLINK HLDG ABsponsored ads$3,563,000
+67.4%
194,390
+38.8%
0.37%
+54.1%
ALLO SellALLOGENE THERAPEUTICS INC$3,502,000
-12.2%
340,000
-2.9%
0.37%
-19.0%
PHR BuyPHREESIA INC$3,415,000
+82.0%
125,000
+66.7%
0.36%
+68.1%
ALKS  ALKERMES PLC$3,405,000
-23.8%
150,0000.0%0.36%
-29.7%
GH SellGUARDANT HEALTH INC$3,218,000
-16.0%
65,000
-31.6%
0.34%
-22.5%
EXAS  EXACT SCIENCES CORP$2,643,000
-11.7%
76,0000.0%0.28%
-18.5%
NTLA  INTELLIA THERAPEUTICS INC$2,639,000
+2.0%
50,0000.0%0.28%
-6.1%
NKTX  NKARTA INC$2,522,000
+2.4%
200,0000.0%0.26%
-5.7%
PHAT  PHATHOM PHARMACEUTICALS INC$2,493,000
+25.6%
235,2100.0%0.26%
+15.5%
ARVN  ARVINAS INC$2,486,000
+18.1%
50,0000.0%0.26%
+8.8%
NVCR SellNOVOCURE LTD$2,473,000
-40.7%
35,000
-41.7%
0.26%
-45.4%
IONS  IONIS PHARMACEUTICALS INC$2,210,000
+19.4%
50,0000.0%0.23%
+10.0%
NKTR  NEKTAR THERAPEUTICS$2,068,000
-1.1%
550,0000.0%0.22%
-8.4%
TXG New10X GENOMICS INC$2,039,00075,000
+100.0%
0.21%
HCAT  HEALTH CATALYST INC$1,588,000
-39.1%
180,0000.0%0.17%
-43.9%
STXS  STEREOTAXIS INC$1,491,000
+1.6%
797,3300.0%0.16%
-6.6%
EPIX  ESSA PHARMA INC$1,350,000
+14.3%
375,0000.0%0.14%
+5.2%
RIGL  RIGEL PHARMACEUTICALS INC$893,000
-35.5%
1,225,0810.0%0.09%
-40.1%
 RAPID MICRO BIOSYSTEMS INC$876,000
-32.1%
300,0000.0%0.09%
-37.4%
ONEM Exit1LIFE HEALTHCARE INC$0-375,250
-100.0%
-0.33%
MYOV ExitMYOVANT SCIENCES LTD$0-310,000
-100.0%
-0.44%
AERI ExitAERIE PHARMACEUTICALS INC$0-562,350
-100.0%
-0.48%
ALGN ExitALIGN TECHNOLOGY INC$0-18,000
-100.0%
-0.48%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
UNITEDHEALTH GROUP INC40Q3 20234.0%
BIOMARIN PHARMACEUTICAL INC40Q3 20235.0%
ALKERMES PLC40Q3 20233.3%
LILLY ELI & CO39Q3 20235.8%
CVS HEALTH CORP39Q3 20233.5%
INTRA-CELLULAR THERAPIES INC39Q3 20232.4%
EDWARDS LIFESCIENCES CORP39Q3 20231.7%
VERTEX PHARMACEUTICALS INC38Q3 20234.3%
REVANCE THERAPEUTICS INC38Q3 20230.9%
ABBVIE INC37Q3 20234.4%

View Rhenman & Partners Asset Management AB's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR/A2023-11-13
13F-HR2023-11-09
13F-HR2023-08-11
13F-HR2023-05-12
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-12
13F-HR2022-05-13
13F-HR2022-02-11

View Rhenman & Partners Asset Management AB's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (955004000.0 != 955010000.0)

Export Rhenman & Partners Asset Management AB's holdings